Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways

E-ISSN： 1873-4286|22|8|987-1012

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.8, 2016-02, pp. : 987-1012

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)

Current Pharmaceutical Design, Vol. 22, Iss. 8, 2016-02 ,pp. : 947-948

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Calcium Channels in Bipolar Disorder

Current Psychopharmacology, Vol. 6, Iss. 2, 2018-01 ,pp. : 122-135

Bentham Science Publishers

Access to resources Recommend Favorite

Newer Antiepileptic Drugs in Bipolar Disorder: Rationale for Use and Role in Therapy

By Macdonald K.J. Young L.T.

CNS Drugs, Vol. 16, Iss. 8, 2002-01 ,pp. : 549-562

Adis International

Access to resources Recommend Favorite

Managing Bipolar Disorder in the Elderly: Defining the Role of the Newer Agents

By Sajatovic Martha Madhusoodanan Subramoniam Coconcea Nicoleta

Drugs & Aging, Vol. 22, Iss. 1, 2005-01 ,pp. : 39-54

Adis International

Access to resources Recommend Favorite

The Role of Newer Antiglutamatergic Agents as Mood-Stabilizers in Bipolar Disorder

Current Drug Targets, Vol. 6, Iss. 5, 2005-08 ,pp. : 607-614

Bentham Science Publishers

Access to resources Recommend Favorite